Buzzy® and Cognitive Behavioral Intervention Package During Blood Draw in Children
The Effect of Buzzy® and a Cognitive Behavioral Intervention Package on Pain and Fear During Blood Draw in Children: A Three-Arm Randomized Controlled Trial
This study evaluated the effects of Buzzy® and a Cognitive Behavioral Intervention Package on pain and fear/anxiety during blood draw in children aged 7-12 years. Blood draw is a common procedure in children, but it may cause pain, fear, and anxiety. Non-pharmacological methods may help children cope better with this procedure.
Children were randomly assigned to one of three groups: a control group, a Cognitive Behavioral Intervention Package group, or a Buzzy® group. Children in the control group received routine blood draw care. Children in the Cognitive Behavioral Intervention Package group received preparation, age-appropriate information, distraction, supportive guidance, parent support, and positive reinforcement. Children in the Buzzy® group received cold and vibration application before and during the blood draw procedure.
Pain and fear/anxiety levels were assessed by child self-report before and immediately after the blood draw. The study aimed to determine whether Buzzy® and the Cognitive Behavioral Intervention Package reduce pain and fear/anxiety compared with routine care.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Needle-related procedures are among the most common sources of procedural pain, fear, and anxiety in children. Blood draw is a short but stressful procedure, and children may experience distress due to needle fear, previous negative experiences, uncertainty about the procedure, and limited coping skills. Poorly managed procedural pain and fear may negatively affect children's future responses to medical procedures.
This study focuses on two non-pharmacological approaches that may support children during blood draw. Buzzy® combines cold and vibration and is intended to reduce pain perception through sensory stimulation. The Cognitive Behavioral Intervention Package includes preparation, age-appropriate information, distraction, supportive communication, parent involvement, and positive reinforcement to help the child cope with the procedure.
The study was designed as a three-arm randomized controlled trial conducted in a pediatric blood drawing unit. The intervention procedures were applied within the routine clinical workflow of the unit. Pain and fear/anxiety were evaluated using child self-report measures before and immediately after the blood draw. By comparing Buzzy®, the Cognitive Behavioral Intervention Package, and routine care, this study aims to provide evidence for practical, child-friendly, and non-pharmacological strategies that can be used by healthcare professionals during pediatric blood draw procedures.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Kocaeli
-
Köseköy, Kocaeli, Turquie (Türkiye)
- Kocaeli University Faculty of Health Sciences
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Enfant
Accepte les volontaires sains
La description
Inclusion Criteria:
- Children aged 7 to 12 years
- Able to read and write
- No chronic disease
- No visual, hearing, verbal communication, cognitive, or neurological impairment
- No use of sedative, analgesic, or narcotic medication within 24 hours before the procedure
- Willingness of both the child and parent to participate in the study
Exclusion Criteria:
- Child's refusal to participate or continue the assessment process
- Parent's request to withdraw from the study
- Inability to complete the blood draw procedure in a single attempt
- Missing essential data required for analysis
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Cognitive Behavioral Intervention Package Group
Children in this group received the Cognitive Behavioral Intervention Package in addition to routine blood draw care.
The package included age-appropriate preparation and information about the blood draw procedure, pre-procedural distraction, supportive suggestions, parent guidance, distraction during the procedure, and positive reinforcement after the procedure.
During the procedure, the child used a selected distraction technique, such as counting, singing, reciting a short poem, or answering questions, with researcher support.
|
The Cognitive Behavioral Intervention Package is a structured, non-pharmacological behavioral intervention applied before, during, and after the blood draw procedure.
Before the procedure, the researcher provides age-appropriate information about the blood draw, answers the child's questions, gives supportive suggestions, guides the parent on how to support the child, and helps the child choose a distraction technique.
During the blood draw, the selected distraction technique, such as counting, singing, reciting a short poem, or answering questions, is applied with researcher support.
After the procedure, the child receives positive verbal feedback and a symbolic reward.
|
|
Expérimental: Buzzy® Group
Children in this group received Buzzy® in addition to routine blood draw care.
Buzzy® is a non-pharmacological device that combines cold and vibration.
The device was applied 60 seconds before the blood draw and was continued during the procedure.
During venipuncture, Buzzy® was placed approximately 3 cm proximal to the blood draw site.
|
Buzzy® is a non-pharmacological device that combines cold and vibration.
In this study, Buzzy® was applied 60 seconds before the blood draw procedure and continued during the procedure.
During venipuncture, the device was placed approximately 3 cm proximal to the blood draw site.
|
|
Aucune intervention: Control Group
Children in this group received routine blood draw care according to the standard procedure of the pediatric blood drawing unit.
No additional non-pharmacological intervention, such as Buzzy® or the Cognitive Behavioral Intervention Package, was applied.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Children's Fear Scale Score
Délai: Immediately before and immediately after the blood draw procedure
|
Fear was assessed using the Children's Fear Scale, a single-item child self-report measure consisting of five faces scored from 0 (no fear) to 4 (extreme fear).
The total score ranges from 0 to 4, with higher scores indicating greater fear and therefore a worse outcome.
Children reported their fear immediately before and immediately after the blood draw procedure.
|
Immediately before and immediately after the blood draw procedure
|
|
Wong-Baker FACES Pain Rating Scale Score
Délai: Immediately before and immediately after the blood draw procedure
|
Pain intensity was assessed using the Wong-Baker FACES® Pain Rating Scale, a single-item child self-report measure consisting of six faces.
In this study, the faces were scored from 0 (no pain) to 5 (the most severe pain).
The total score ranges from 0 to 5, with higher scores indicating greater pain intensity and therefore a worse outcome.
Children reported their pain immediately before and immediately after the blood draw procedure.
|
Immediately before and immediately after the blood draw procedure
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Birgül Erdoğan, Kocaeli University
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- KOU-GOKAEK-2024-16-13
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .